Reviewed, UniProtKB/Swiss-Prot P31939 (PUR9_HUMAN)

Names and origin

Protein names

Recommended name:
    Bifunctional purine biosynthesis protein PURH
Including the following 2 domains:
    1- Recommended name:
            Phosphoribosylaminoimidazolecarboxamide formyltransferase
              EC=2.1.2.3
        Alternative name(s):
            5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase
            AICAR transformylase
    2- Recommended name:
            IMP cyclohydrolase
              EC=3.5.4.10
        Alternative name(s):
            Inosinicase
            IMP synthetase
            ATIC

Gene names

Name:	ATIC
Synonyms:	PURH
ORF Names:	OK/SW-cl.86

Organism

Homo sapiens (Human)

Taxonomic identifier

9606 [NCBI]

Taxonomic lineage

Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo

Protein attributes

Sequence length	592 AA.
Sequence status	Complete.
Sequence processing	The displayed sequence is not processed.
Protein existence	Evidence at protein level.

General annotation (Comments)

Catalytic activity	10-formyltetrahydrofolate + 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide = tetrahydrofolate + 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide. IMP + H2O = 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide.
Pathway	Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1.
Domain	The IMP cyclohydrolase activity resides in the N-terminal region.
Involvement in disease	Defects in ATIC are the cause of AICA-ribosuria [MIM:608688]; also known as AICA-ribosiduria. AICA-ribosuria is a neurologically devastating inborn error of purine biosynthesis. AICA-ribosuria patients excrete massive amounts of AICA-riboside in the urine and accumulate AICA-ribotide and its derivatives in erythrocytes and fibroblasts. AICA-ribosuria causes profound mental retardation, epilepsy, dysmorphic features and congenital blindness. Ref.11
Sequence similarities	Belongs to the purH family.

Ontologies

Keywords
Biological process	Purine biosynthesis
Coding sequence diversity	Polymorphism
Disease	Disease mutation Epilepsy
Molecular function	Hydrolase Transferase
PTM	Phosphoprotein
Technical term	3D-structure Direct protein sequencing Multifunctional enzyme
Gene Ontology (GO)
Biological process	IMP biosynthetic process Inferred from electronic annotation. Source: InterPro
Molecular function	IMP cyclohydrolase activity Ref.1 Traceable author statement. Source: ProtInc phosphoribosylaminoimidazolecarboxamide formyltransferase activity Ref.1 Traceable author statement. Source: ProtInc protein binding Inferred from physical interaction. Source: IntAct
Complete GO annotation...

Binary interactions

With	Entry	#Exp.	IntAct	Notes
CMBL	Q96DG6	1	EBI-1048599,EBI-1044268
ELF3	P78545	1	EBI-1048599,EBI-1057285
HNRPDL	O14979	1	EBI-1048599,EBI-299727
IKBKE	Q14164	1	EBI-1048599,EBI-307369
NDUFAF1	Q9Y375	1	EBI-1048599,EBI-741874
NME2	P22392	1	EBI-1048599,EBI-713693
PSTPIP1	O43586	1	EBI-1048599,EBI-1050964
RADIL	Q96JH8	1	EBI-1048599,EBI-744267
SNRPA	P09012	1	EBI-1048599,EBI-607085
STOM	P27105	1	EBI-1048599,EBI-1211440

Sequence annotation (Features)

Feature key

Position(s)

Length

Description

Graphical view

Feature identifier

Molecule processing

Chain

1 – 592

592

Bifunctional purine biosynthesis protein PURH

PRO_0000192156

Amino acid modifications

Modified residue

104

1

Phosphotyrosine Ref.9

Natural variations

Natural variant

116

1

T → S: dbSNP rs2372536.

VAR_019306

Natural variant

426

1

K → R in AICA-ribosuria; loss of AICAR transformylase activity.

VAR_019307

Experimental info

Sequence conflict

1 – 6

6

MAPGQL → MSSLS Ref.1

Sequence conflict

165

1

D → G in AAA97405. Ref.1

Secondary structure

1

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

592

Helix Strand Turn

Details...

Beta strand

6 – 10

5

Helix

17 – 25

9

Turn

26 – 28

3

Beta strand

30 – 33

4

Helix

35 – 42

8

Turn

43 – 45

3

Helix

51 – 55

5

Turn

61 – 64

4

Beta strand

65 – 67

3

Helix

70 – 77

8

Helix

82 – 91

10

Beta strand

96 – 101

6

Helix

106 – 111

6

Helix

117 – 122

6

Helix

127 – 137

11

Turn

138 – 141

4

Beta strand

143 – 145

3

Helix

148 – 150

3

Helix

151 – 160

10

Helix

168 – 197

30

Turn

200 – 202

3

Beta strand

203 – 207

5

Beta strand

209 – 211

3

Beta strand

217 – 220

4

Beta strand

222 – 225

4

Beta strand

227 – 233

7

Helix

237 – 257

21

Beta strand

261 – 266

6

Beta strand

269 – 275

7

Helix

281 – 286

6

Helix

290 – 295

6

Helix

298 – 308

11

Turn

311 – 316

6

Beta strand

317 – 323

7

Helix

327 – 334

8

Beta strand

338 – 344

7

Helix

348 – 360

13

Beta strand

363 – 367

5

Beta strand

375 – 381

7

Beta strand

384 – 389

6

Helix

397 – 400

4

Helix

412 – 426

15

Beta strand

433 – 437

5

Beta strand

440 – 445

6

Helix

451 – 467

17

Helix

471 – 474

4

Helix

486 – 496

11

Helix

503 – 509

7

Beta strand

512 – 514

3

Helix

521 – 528

8

Beta strand

534 – 540

7

Helix

546 – 552

7

Turn

553 – 555

3

Beta strand

556 – 562

7

Helix

568 – 578

11

Beta strand

581 – 586

6

Sequences

	Sequence		Length	Mass (Da)
	P31939-1 [UniParc]. Last modified October 10, 2002. Version 3. Checksum: AD778892021F0888	FASTA	592	64,616
	10 20 30 40 50 60 MAPGQLALFS VSDKTGLVEF ARNLTALGLN LVASGGTAKA LRDAGLAVRD VSELTGFPEM 70 80 90 100 110 120 LGGRVKTLHP AVHAGILARN IPEDNADMAR LDFNLIRVVA CNLYPFVKTV ASPGVTVEEA 130 140 150 160 170 180 VEQIDIGGVT LLRAAAKNHA RVTVVCEPED YVVVSTEMQS SESKDTSLET RRQLALKAFT 190 200 210 220 230 240 HTAQYDEAIS DYFRKQYSKG VSQMPLRYGM NPHQTPAQLY TLQPKLPITV LNGAPGFINL 250 260 270 280 290 300 CDALNAWQLV KELKEALGIP AAASFKHVSP AGAAVGIPLS EDEAKVCMVY DLYKTLTPIS 310 320 330 340 350 360 AAYARARGAD RMSSFGDFVA LSDVCDVPTA KIISREVSDG IIAPGYEEEA LTILSKKKNG 370 380 390 400 410 420 NYCVLQMDQS YKPDENEVRT LFGLHLSQKR NNGVVDKSLF SNVVTKNKDL PESALRDLIV 430 440 450 460 470 480 ATIAVKYTQS NSVCYAKNGQ VIGIGAGQQS RIHCTRLAGD KANYWWLRHH PQVLSMKFKT 490 500 510 520 530 540 GVKRAEISNA IDQYVTGTIG EDEDLIKWKA LFEEVPELLT EAEKKEWVEK LTEVSISSDA 550 560 570 580 590 FFPFRDNVDR AKRSGVAYIA APSGSAADKV VIEACDELGI ILAHTNLRLF HH

References

	« Hide 'large scale' referencesShow 'large scale' references »
[1]	"The human purH gene product, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase. Cloning, sequencing, expression, purification, kinetic analysis, and domain mapping." Rayl E.A., Moroson B.A., Beardsley G.P. J. Biol. Chem. 271:2225-2233(1996) [PubMed: 8567683] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Hepatoma.
[2]	"Isolation of human purH gene expressed in the rodent transformant cells by subtractive enrichment of 3'-untranslated region of human transcript." Yamauchi M., Seki N., Mita K., Saito T., Tsuji S., Hongo E., Morimyo M., Shiomi T., Koyama H. DNA Res. 2:269-275(1995) [PubMed: 8867801] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Testis.
[3]	"Characterization of molecularly cloned human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase." Sugita T., Aya H., Ueno M., Ishizuka T., Kawashima K. J. Biochem. 122:309-313(1997) [PubMed: 9378707] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Placenta.
[4]	"Identification of immuno-peptidmics that are recognized by tumor-reactive CTL generated from TIL of colon cancer patients." Shichijo S., Itoh K. Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Colon adenocarcinoma.
[5]	"Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. , Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., Wilson R.K. Nature 434:724-731(2005) [PubMed: 15815621] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[6]	"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Pancreas.
[7]	Lubec G., Vishwanath V., Chen W.-Q., Sun Y. Submitted (DEC-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 15-39; 91-97; 178-194; 208-225; 267-285 AND 417-426, MASS SPECTROMETRY. Tissue: Brain, Cajal-Retzius cell and Fetal brain cortex.
[8]	"Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes." Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E., Vandekerckhove J. Electrophoresis 13:960-969(1992) [PubMed: 1286667] [Abstract] Cited for: PROTEIN SEQUENCE OF 178-189 AND 267-281. Tissue: Keratinocyte.
[9]	"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer." Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. , Yuan J., Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X., Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J. Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-104, MASS SPECTROMETRY.
[10]	Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY.
[11]	"AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC." Marie S., Heron B., Bitoun P., Timmerman T., Van Den Berghe G., Vincent M.-F. Am. J. Hum. Genet. 74:1276-1281(2004) [PubMed: 15114530] [Abstract] Cited for: VARIANT AICA-RIBOSURIA ARG-426, CHARACTERIZATION OF VARIANT AICA-RIBOSURIA ARG-426.
+	Additional computationally mapped references.

Web resources

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Cross-references

Sequence databases

EMBLGenBankDDBJ

U37436 mRNA. Translation: AAA97405.1.
D82348 mRNA. Translation: BAA11559.1.
D89976 mRNA. Translation: BAA21762.1.
AB062403 mRNA. Translation: BAB93490.1.
AC073284 Genomic DNA. Translation: AAY24062.1.
BC008879 mRNA. Translation: AAH08879.1.

IPI

IPI00289499.

PIR

JC4642.

RefSeq

NP_004035.2.

UniGene

Hs.90280

3D structure databases

PDBPDBe

Entry	Method	Resolution (Å)	Chain	Positions	PDBsum
1P4R	X-ray	2.55	A/B	1-592	[»]
1PKX	X-ray	1.90	A/B/C/D	1-592	[»]
1PL0	X-ray	2.60	A/B/C/D	1-592	[»]

ModBase

Search...

Protein-protein interaction databases

IntAct

P31939. 15 interactions.

PTM databases

PhosphoSite

P31939.

2-D gel databases

Aarhus/Ghent-2DPAGE

2403. IEF.

REPRODUCTION-2DPAGE

IPI00289499.

Proteomic databases

PeptideAtlas

P31939.

PRIDE

P31939.

Genome annotation databases

Ensembl

ENSG00000138363. Homo sapiens. [Contig view]

GeneID

471.

KEGG

hsa:471.

Organism-specific databases

GeneCards

GC02P215885.

H-InvDB

HIX0002802.

HGNC

HGNC:794. ATIC.

HPA

CAB013462.

MIM

601731. gene.
608688. phenotype.

PharmGKB

PA25094.

GenAtlas

Search...

Phylogenomic databases

HOGENOM

P31939.

HOVERGEN

P31939.

OMA

P31939. VVKHVKS.

Enzyme and pathway databases

BRENDA

2.1.2.3. 247.
3.5.4.10. 247.

Reactome

REACT_1698. Nucleotide metabolism.

Gene expression databases

ArrayExpress

P31939.

Bgee

P31939.

CleanEx

HS_ATIC.

GermOnline

ENSG00000138363. Homo sapiens.

Family and domain databases

InterPro

IPR002695. AICARFT_IMPCHas.
IPR013982. AICARFT_IMPCHas_formly.
IPR011607. MGS.
[Graphical view]

PANTHER

PTHR11692. AICARFT_IMPCHas. 1 hit.

Pfam

PF01808. AICARFT_IMPCHas. 1 hit.
PF02142. MGS. 1 hit.
[Graphical view]

PIRSF

PIRSF000414. AICARFT_IMPCHas. 1 hit.

SMART

SM00798. AICARFT_IMPCHas. 1 hit.
[Graphical view]

TIGRFAMs

TIGR00355. purH. 1 hit.

ProtoNet

Search...

Other Resources

BindingDB

P31939.

DrugBank

DB00116. Tetrahydrofolic acid.

NextBio

1945.

SOURCE

Search...

Entry information

Entry name

PUR9_HUMAN

Accession

Primary (citable) accession number: P31939
Secondary accession number(s): Q13856, Q53S28

Entry history

Integrated into UniProtKB/Swiss-Prot:	July 1, 1993
Last sequence update:	October 10, 2002
Last modified:	June 16, 2009
This is version 97 of the entry and version 3 of the sequence. [Complete history]

Entry status

Reviewed (UniProtKB/Swiss-Prot)

Annotation project

HPI (Human Proteome Initiative)